ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 136 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $588,000 | -2.0% | 48,800 | +317.1% | 0.01% | -14.3% |
| Q2 2020 | $600,000 | +192.7% | 11,700 | +80.0% | 0.01% | +133.3% |
| Q1 2020 | $205,000 | -58.6% | 6,500 | -21.7% | 0.00% | -40.0% |
| Q4 2019 | $495,000 | +7.1% | 8,300 | -34.1% | 0.01% | 0.0% |
| Q3 2019 | $462,000 | +111.0% | 12,600 | +168.1% | 0.01% | +66.7% |
| Q2 2019 | $219,000 | -36.9% | 4,700 | -2.1% | 0.00% | -25.0% |
| Q1 2018 | $347,000 | +22.6% | 4,800 | -78.8% | 0.00% | 0.0% |
| Q4 2016 | $283,000 | +16.9% | 22,600 | +29.1% | 0.00% | +33.3% |
| Q3 2016 | $242,000 | – | 17,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
| Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
| Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
| Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
| Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
| Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
| Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
| BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
| Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
| Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |